Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Colitis, Ulcerative
United States, Argentina, Australia, Austria, Belgium +32 more
Sponsor: Janssen Research & Development, LLC
Non-Muscle Invasive Bladder Neoplasms
United States, Argentina, Belgium, Brazil, China +10 more
- An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic CholangiocarcinomaActive Not Recruiting
Sponsor: Servier Affaires Médicales
Cholangiocarcinoma
Armenia, Australia, Austria, Belgium, Canada +11 more
Sponsor: Janssen Research & Development, LLC
Advanced or Metastatic Non-small Cell Lung Cancer
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: Janssen Research & Development, LLC
Lupus Erythematosus, Systemic
United States, Argentina, Australia, Brazil, Bulgaria +24 more
Sponsor: Janssen Research & Development, LLC
Neoplasms
United States, Canada, China, France, Germany +5 more
Sponsor: Janssen Research & Development, LLC
Hemolytic Disease of the Fetus and Newborn
United States, Argentina, Australia, Austria, Belgium +12 more
- Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Endometrial Clear Cell Adenocarcinoma · Endometrial Dedifferentiated Carcinoma · Endometrial Endometrioid Adenocarcinoma · Endometrial Mixed Cell Adenocarcinoma
United States, Canada, Japan, Puerto Rico, South Korea
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Squamous Cell Carcinoma of Head and Neck
United States, France, Japan
- A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical PracticeActive Not Recruiting
Sponsor: Janssen Pharmaceutica N.V., Belgium
Arthritis, Psoriatic
Argentina, Australia, Austria, Belgium, Canada +15 more
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
Sponsor: Janssen Research & Development, LLC
Crohn Disease
United States, Australia, Brazil, Canada, Israel +4 more
Sponsor: AbbVie
Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma
Japan
Sponsor: Janssen Research & Development, LLC
Colorectal Neoplasms
United States, Australia, Belgium, Brazil, China +21 more
Sponsor: Janssen Research & Development, LLC
Multiple Myeloma
United States, Australia, China, France, Germany +10 more
- Study of Erdafitinib Intravesical Delivery System for Localized Bladder CancerActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Non-Muscle Invasive Bladder Neoplasms
United States, Canada, Germany, Israel, Japan +3 more
Sponsor: Janssen Research & Development, LLC
Metastatic Castration-resistant Prostate Neoplasms
United States, Australia, Belgium, Brazil, Canada +12 more
Sponsor: Janssen Research & Development, LLC
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
United States, Argentina, Australia, Canada, China +14 more
Sponsor: Arcus Biosciences, Inc.
Metastatic Clear Cell Renal Cell Carcinoma · Advanced Clear Cell Renal Cell Carcinoma
United States, Argentina, Australia, Canada, Czechia +11 more
- A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the BladderActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Urinary Bladder Neoplasms
United States, Argentina, Australia, Austria, Belgium +20 more
- A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer TherapiesActive Not Recruiting
Sponsor: Regeneron Pharmaceuticals
B-cell Non-Hodgkin Lymphoma (B-NHL)
United States, Australia, Canada, China, France +9 more
Sponsor: Janssen Research & Development, LLC
Acute Leukemia
United States, Australia, Belgium, Brazil, Canada +8 more
Sponsor: Janssen Research & Development, LLC
Prostatic Neoplasms
United States, Australia, China, France, Japan
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisActive Not Recruiting
Sponsor: Janssen Research & Development, LLC
Colitis, Ulcerative
United States, Australia, Belgium, China, Denmark +8 more
Sponsor: Janssen Research & Development, LLC
Urinary Bladder Neoplasms
United States, Australia, Belgium, Canada, France +11 more
Sponsor: Janssen Research & Development, LLC
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Mantle Cell Lymphoma · Follicular Lymphoma
United States, Argentina, Australia, Belgium, Brazil +25 more